Feedback / Questions
CardiAMP Cell Therapy (BCDA-01) - BioCardia
https://www.globenewswire.com/news-release/2025/05/01/3072465/0/en/BioCardia-Announces-First-Patient-in-Phase-3-Randomized-Controlled-Double-Blind-CardiAMP-HF-II-Clinical-Trial-of-the-Company-s-Lead-Cell-Therapy-for-Treatment-of-Heart-Failure.html
May 1, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next